Lacticaseibacillus rhamnosus on the European supplement market
Most ingredient pages tell you what Lacticaseibacillus rhamnosus is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 147 Lacticaseibacillus rhamnosus products from 68 brands across the EU and US. 0 brands advertise it on Meta right now, and new-ad activity held roughly steady in the last 30 days. Germany shows the heaviest advertising, while Germany has the largest shelf. The median EU shelf price sits around €29.
How brands use Lacticaseibacillus rhamnosus, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 48 | 19 | — | — | €42.90 |
| United Kingdom | 32 | 12 | — | — | £18.47 |
| France | 7 | 5 | — | — | €27.73 |
| Italy | 13 | 10 | — | — | €23.50 |
| Spain | 10 | 7 | — | — | €23.56 |
| Romania | 8 | 6 | — | — | 46.90 RON |
| United States | 3 | 3 | — | — | — |
| Austria | 2 | 1 | — | — | — |
Who is on the shelf right now
Top brands by number of Lacticaseibacillus rhamnosus products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| Lacticaseibacillus rhamnosus | 23 |
| Lacticaseibacillus rhamnosus (strain LR06) | 21 |
| Lacticaseibacillus rhamnosus (strain Rosell-11) | 17 |
| Lacticaseibacillus rhamnosus (strain LRa66) | 12 |
| Lacticaseibacillus rhamnosus (GG) | 10 |
| Lacticaseibacillus rhamnosus (strain NJ551) | 10 |
Regulatory & positioning
| Botanical source | Lacticaseibacillus rhamnosus |
|---|---|
| Novel food status | Not novel in food |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | gut health, immunity |
No EFSA-authorized health claim exists for Lacticaseibacillus rhamnosus, yet brands market it for gut health, immunity — the gap between claim and positioning is itself a competitive signal.
Where Lacticaseibacillus rhamnosus shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is Lacticaseibacillus rhamnosus?
Lacticaseibacillus rhamnosus is a probiotic bacterium commonly used in dietary supplements. It belongs to the group of beneficial microorganisms often included in formulations aimed at gut health and immune system support. This ingredient is typically found in capsules, powders, and functional foods designed for digestive wellness and general health maintenance. As a probiotic, Lacticaseibacillus rhamnosus is incorporated into products marketed for balancing intestinal flora and contributing to overall microbial diversity in the gastrointestinal tract.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access